Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000
Yahoo Finance · 2 weeks ago
Ad
related to: vktx stock newsMarket and Investing Insights from Our Investment Professionals to You. Subscribe Now. Get Access to Our In-Depth Global Research on Equities, Fixed Income and the Economy.
- Fixed Income Outlook
View the Latest Fixed Income
Investment Insights.
- White Papers
Explore our Research Findings
on a Range of Topics.
- Market Economy Trends
Review the Latest World
Markets Investment Insights.
- Inflation Rate News
Get Our Latest Thinking on
Inflation Rate Impacts.
- Fixed Income Capabilities
50 Years of Fixed Income Investing.
A Distinctive Approach. Learn More.
- Capital Ideas Podcast
Insights From CEO Mike Gitlin and
Investment Professionals.
- Fixed Income Outlook
Search results
- 65.36Add to watchlist+2.61 (+4.16%)At close:4:00 PM EDTTue. May 28, 202465.10 -0.26 (-0.40%)After hrs:4:43 PM EDTTue. May 28, 2024Nasdaq Real Time Price (USD) · Market closed
- Open63.50High65.90Low62.33
- Mkt Cap7.21BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close62.7552 Wk. Low8.2852 Wk. High99.41
Top storiesRelated stocks
Motley Fool • yesterday. VKTX. +1.92% 2 Stocks That Could 10x by 2035. These stocks are very promising, but it's important to consider the downside, too. Motley Fool • 2 days ago. VKTX....
Viking Therapeutics, Inc. (VKTX) Stock Price, News, Quote & History - Yahoo Finance. NasdaqCM - Delayed Quote • USD. Viking Therapeutics, Inc. (VKTX) +1.18 (+1.92%) At close:...
Feb 27, 2024 · VK2735, a dual GLP-1/GIP receptor agonist, demonstrated statistically significant weight loss and safety in patients with obesity. The company plans to meet with the FDA and discuss next steps in the development of VK2735.
Get the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Feb 28, 2024 · VKTX announced positive results from a Phase 2 trial of VK2735, a GLP-1 receptor agonist for obesity and diabetes. The stock more than doubled to a record high, as investors cheered the cheap entry to the weight-loss-drug craze.
5 days ago · A high-level overview of Viking Therapeutics, Inc. (VKTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
6 days ago · Before Lilly’s Zepbound and Novo’s Wegovy arrived on the scene, new weight-loss drugs from small-scale biotechs struggled commercially or worse. Today, Viking is racing alongside a slew of ...
Ad
related to: vktx stock newsMarket and Investing Insights from Our Investment Professionals to You. Subscribe Now. Get Access to Our In-Depth Global Research on Equities, Fixed Income and the Economy.
